Home/Filings/4/0001654954-22-000247
4//SEC Filing

Perlysky Dov 4

Accession 0001654954-22-000247

CIK 0001304161other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:10 PM ET

Size

15.0 KB

Accession

0001654954-22-000247

Insider Transaction Report

Form 4
Period: 2022-01-04
Perlysky Dov
Director
Transactions
  • Exercise/Conversion

    Stock Option

    2022-01-0420,0000 total
    Exercise: $0.91Exp: 2022-01-10Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-01-04$0.52/sh+10,000$5,20049,337 total
  • Tax Payment

    Common Stock

    2022-01-04$1.03/sh5,049$5,20044,288 total
  • Exercise/Conversion

    Stock Option

    2022-01-0410,0000 total
    Exercise: $0.52Exp: 2023-01-10common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-01-04$0.91/sh+20,000$18,20057,007 total
  • Tax Payment

    Common Stock

    2022-01-04$1.03/sh17,670$18,20039,337 total
Holdings
  • Common Stock

    (indirect: Managing Member)
    1,164,554
  • Common Stock

    (indirect: By Spouse)
    772,791
Footnotes (6)
  • [F1]Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
  • [F2]Shares reported in this column have been updated to properly reflect the shares held by the reporting person following the transactions on January 4, 2021.
  • [F3]The Reporting Person is the Managing Member of Krovim LLC, which owns the 1,164,554 shares of common stock reported herein.
  • [F4]The Reporting Person's wife is the Managing Member of LDP Family Partnership, which owns the 772,791 shares of common stock, of which the Reporting Person disclaims beneficial ownership.
  • [F5]The option vested in two equal installments on July 10, 2017 and July 10, 2018.
  • [F6]The option vested in two equal installments on July 10, 2018 and July 10, 2019.

Issuer

Pharma-Bio Serv, Inc.

CIK 0001304161

Entity typeother

Related Parties

1
  • filerCIK 0001072922

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:10 PM ET
Size
15.0 KB